Moreover, when we inhibited the expression of VHL in HCC cells with downregulated UBE2S, the results showed that the inhibition of the JAK/STAT signaling pathway induced by downregulation of UBE2S was reversed. The gene discussed is UBE2S; the disease is hepatocellular carcinoma.